[The efficacy of intestinal dysbacteriosis correction in patients with bronchial asthma].
Altogether 119 patients with infectious-allergic bronchial asthma were examined for intestinal dysbacteriosis and for the immune status (T and B lymphocytes, TPS-RFC, TPR-RFC, IgA, IgM and IgG in blood and feces). Intestinal dysbacteriosis was discovered in 79.8 percent of the cases, more frequently in grave asthma course. Sixteen patients with grades II-III dysbacteriosis were treated with the bacterial preparations (colibacterin, bifidobacterin or bifikol) under outpatient conditions. As a result of the treatment the clinical signs of intestinal dysbacteriosis disappeared, the fecal microflora improved and the immune status returned to normal. However the blood concentration of IgG remained high.
Polosukhina
V A
VA
Uzhegova
E B
EB
Babadzhanova
S S
SS
D001249:Asthma / Q000276:immunology / Q000382:microbiology*; D001430:Bacteriocins / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D001772:Blood Cell Count; D003087:Colicins / Q000627:therapeutic use; D005243:Feces / Q000032:analysis / Q000382:microbiology; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007422:Intestines / Q000382:microbiology*; D008214:Lymphocytes; D012397:Rosette Formation
D001430:Bacteriocins; D001688:Biological Products; D003087:Colicins; D007136:Immunoglobulins; C010546:bifidobacterin; C012775:bifikol; C016501:colibacterin
Effektivnost' korrektsii kishechnogo disbakterioza u bol'nykh bronkhial'noĭ astmoĭ.